These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 31581474

  • 1. Structural Basis for the Regulation of PPARγ Activity by Imatinib.
    Jang JY, Kim HJ, Han BW.
    Molecules; 2019 Oct 01; 24(19):. PubMed ID: 31581474
    [Abstract] [Full Text] [Related]

  • 2. Structural basis for the inhibitory effects of a novel reversible covalent ligand on PPARγ phosphorylation.
    Jang JY, Kim H, Kim HJ, Suh SW, Park SB, Han BW.
    Sci Rep; 2019 Aug 01; 9(1):11168. PubMed ID: 31371757
    [Abstract] [Full Text] [Related]

  • 3. Structural basis for differential activities of enantiomeric PPARγ agonists: Binding of S35 to the alternate site.
    Jang JY, Koh M, Bae H, An DR, Im HN, Kim HS, Yoon JY, Yoon HJ, Han BW, Park SB, Suh SW.
    Biochim Biophys Acta Proteins Proteom; 2017 Jun 01; 1865(6):674-681. PubMed ID: 28342850
    [Abstract] [Full Text] [Related]

  • 4. Structural Basis for the Enhanced Anti-Diabetic Efficacy of Lobeglitazone on PPARγ.
    Jang JY, Bae H, Lee YJ, Choi YI, Kim HJ, Park SB, Suh SW, Kim SW, Han BW.
    Sci Rep; 2018 Jan 08; 8(1):31. PubMed ID: 29311579
    [Abstract] [Full Text] [Related]

  • 5. Structural insight into PPARgamma activation through covalent modification with endogenous fatty acids.
    Waku T, Shiraki T, Oyama T, Fujimoto Y, Maebara K, Kamiya N, Jingami H, Morikawa K.
    J Mol Biol; 2009 Jan 09; 385(1):188-99. PubMed ID: 18977231
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Atomic structure of mutant PPARgamma LBD complexed with 15d-PGJ2: novel modulation mechanism of PPARgamma/RXRalpha function by covalently bound ligands.
    Waku T, Shiraki T, Oyama T, Morikawa K.
    FEBS Lett; 2009 Jan 22; 583(2):320-4. PubMed ID: 19101554
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Insights into PPARγ Phosphorylation and Its Inhibition Mechanism.
    Montanari R, Capelli D, Yamamoto K, Awaishima H, Nishikata K, Barendregt A, Heck AJR, Loiodice F, Altieri F, Paiardini A, Grottesi A, Pirone L, Pedone E, Peiretti F, Brunel JM, Itoh T, Pochetti G.
    J Med Chem; 2020 May 14; 63(9):4811-4823. PubMed ID: 32239932
    [Abstract] [Full Text] [Related]

  • 13. Peroxisome Proliferator-Activated Receptor γ (PPARγ) and Ligand Choreography: Newcomers Take the Stage.
    Garcia-Vallvé S, Guasch L, Tomas-Hernández S, del Bas JM, Ollendorff V, Arola L, Pujadas G, Mulero M.
    J Med Chem; 2015 Jul 23; 58(14):5381-94. PubMed ID: 25734377
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Selective targeting of PPARγ by the natural product chelerythrine with a unique binding mode and improved antidiabetic potency.
    Zheng W, Qiu L, Wang R, Feng X, Han Y, Zhu Y, Chen D, Liu Y, Jin L, Li Y.
    Sci Rep; 2015 Jul 17; 5():12222. PubMed ID: 26183621
    [Abstract] [Full Text] [Related]

  • 16. Structural review of PPARγ in complex with ligands: Cartesian- and dihedral angle principal component analyses of X-ray crystallographic data.
    Kaupang Å, Laitinen T, Poso A, Hansen TV.
    Proteins; 2017 Sep 17; 85(9):1684-1698. PubMed ID: 28543443
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.